CharltonB., SchindhelmK., FarrellP.C.Effect of extracorporeal IgG removal on IgG kinetics.Trans Am Soc Artif Intern Organs1983; 29: 724–8.
2.
GlöcknerW.M., SieberthH-G, GressnerA.Different recovery of plasma proteins after reduction by plasmapheresis. In: NoséY., MalcheskyP.S., SmithJ.W., eds. Plasmapheresis. New trends in therapeutic application.Cleveland: ISAO Press, 1983; 33–6.
3.
EulerH-H, KreyU., GutschmidtH-J, LöfflerH.Partial synchronization of plasmapheresis and immunosuppression in autoimmune diseases: experimental and clinical results. In: NoséY., MalcheskyP.S., SmithJ.W., eds. Therapeutic apheresis: A critical look.Cleveland: ISAO Press, 1984; 225–9.
4.
SchöchG., Heller-SchöchG., MüllerJ., HeddrichM., GrüttnerR.Determination of RNA - metabolism as indicator of nutritional status.Klin Pädiat1982; 194: 317–9.
5.
SalvatoreF., SavoiaM., RussoT., SacchettiL., CiminoF.Pseudouridine in biological fluids of tumor-bearing patients. In: CiminoF., BirkmayerG.D., KlavinsJ.V., PimentelE., SalavatoreF., eds. Human tumor markers.Berlin, New York: Walter de Gruyter & Co., 1987; 451–62.
6.
LajdováI., SpustováV., MikulaJ., CernayP., DzúrikR.Isolation of an additional inhibitor of glucose utilization in renal insufficiency.Journal Chromatography1990; 528: 178–83.
7.
SprengerK.B.G.Prediction of patient's plasma volume in plasma exchange therapy. In: SmebyL.C., eds. Immune and metabolic aspects of therapeutic blood purification systems.Basel: Karger, 1986; 394–402.
8.
SchootsA.C., GerlagP.G.G., MulderA.W., PeetersJ.A.G., CramersCAMGLiquid - chromatographic profiling of solutes in serum of uremic patients undergoing hemodialysis and chronic ambulatory peritoneal dialysis (CAPD): high concentrations of pseudouridin in CAPD patients.Clinical Chemistry1988; 34: 91–7.